Events
Activities held in partnership with Dubai Health Authority
The highly successful thirteenth annual BIO-Europe Spring® international partnering conference wrapped up in Vienna, Austria, last week with a record 2,570 biotech, pharma and investment attendees who engaged in 15,428 one-to-one partnering meetings vying for over 3,600 licensing opportunities on offer.
Single intravenous dose phase 1 trial showed that AIC649 was safe and well tolerated in all dose groups
Elafibranor Phase 2 data in PBC accepted for late-breaker oral presentation
Motif Bio plc, a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announced that four iclaprim abstracts have been accepted for presentation at the upcoming 28th European Congress of Clinical Microbiology and Infectious Diseases to be held in Amsterdam, The Netherlands, April 13-16, 2019.
Polyphor AG announced that 5 abstracts featuring data on its Outer Membrane Targeting Antibiotics, including both its lead product candidate murepavadin and its new medium-spectrum anti Gram-negative lead preclinical compound, will be presented at the 29th European Congress of Clinical Microbiology and Infectious Diseases taking place in Amsterdam, Netherlands, from April 13 to16, 2019.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Bill Gates, Jeff Bezos and MacKenzie Bezos have teamed to donate over $20 million to the Diagnostics Accelerator, a project that is part of the Alzheimer’s Drug Discovery Foundation (ADDF).
Bedfont® Scientific Ltd. scoops Exporter of the Year for the 3rd time in a row at the Kent Invicta Chamber of Commerce awards.
ViiV Healthcare, presented three-year data from the SWORD 1 and 2 clinical trials in HIV. The data was presented at the 25th Annual Conference of the British HIV Association (BHIVA) in Bournemouth, UK.
PRESS RELEASES